Prof. Peyman Hadji

Prof. Peyman Hadji currently heads the Frankfurt Centre of Bone Health in Germany. His research focuses on bone health in women with breast cancer, particularly cancer-and aromatase inhibitor–induced bone loss. Prof. Hadji is the lead author of international guidance on managing AIBL and a co-author of ESMO and national German guidelines on bone health and breast cancer. He serves as Vice President of the DVO, on the boards of CABS and the German Menopause Society (DMG), and CSA member of the IOF. He has published over 300 peer-reviewed articles in the field and is Editor-in-Chief of the Journal of Bone Oncology.